Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of TTF2 mRNA | affects expression | 21346803
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of TTF2 protein | affects expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of TTF2 mRNA | increases expression | 20106945
|
D004317 |
Doxorubicin |
TTF2 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D008727 |
Methotrexate |
TTF2 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TTF2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TTF2 mRNA | affects binding|increases activity|increases expression | 19710929
|
D011374 |
Progesterone |
Progesterone results in increased expression of TTF2 mRNA | increases expression | 18070364
|
D014747 |
Vinblastine |
TTF2 protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.58 | 12039119 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.61 | 17418594 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.82 | 16434500 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.83 | 21441931 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.14 | 17286800 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.39 | 19483382 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.08 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.71 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.56 | 15665606 15380490 15845082 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.04 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.10 | 15668708 17426702 18628466 15567936 19526202 16322301 16096432 15692762 16826403 11325840 16595493 15136595 18234424 16935488 15939500 17369602 16264153 15993339 16115903 18695136 18382427 15634643 15994142 17983394 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.10 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.10 | 17614352 15562024 16175315 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.19 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.83 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.83 | 12619106 12907637 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.83 | 18059187 16234567 16023760 17876044 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
7.28 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
7.28 | 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.69 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.68 | 15811867 17131338 15792986 16364871 16952015 16455267 17928571 16109756 16278810 15505089 17351982 16731534 17382496 17308081 16651473 15476868 18627295 16612575 17974986 17519947 17924179 16269455 17329180 17007740 16242529 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.01 | 16243910 17334414 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.68 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.35 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.35 | 19176532 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.98 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
2.98 | 18802399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.66 | 9562676 12039119 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.32 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.47 | 19747007 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.41 | 20191521 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.80 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.23 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
4.23 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.84 | 18602426 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.72 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.06 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.60 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.99 | 16134523 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.53 | 18037988 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.38 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.38 | 20131406 19236843 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.93 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.45 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.56 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.49 | 17150277 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.45 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.68 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.64 | 12587719 16495754 17888722 16244372 16244371 16330681 17875725 14766674 16879835 18006777 18674790 16707910 16144979 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.51 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.51 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.14 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.76 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.30 | 18467677 19176532 16221962 19772884 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
8.52 | 15147373 18501091 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
8.52 | 18180244 18501091 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.17 | 10903974 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.71 | 15869954 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.70 | 15869954 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.78 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.82 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.53 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.53 | 16775033 15369732 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.40 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
7.95 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.95 | 12371664 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.36 | 9562676 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.53 | 16085563 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.82 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.53 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.53 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
4.74 | 18177683 2125692 9163691 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.74 | 16377806 20007298 15890375 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.61 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.61 | 17085340 16842330 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.40 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.69 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.69 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
8.48 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
8.48 | 17352296 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.99 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.87 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.72 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.72 | 17203775 11408345 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
3.90 | 16827129 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
3.90 | 15577323 12374674 18176117 17761969 16809738 18505091 15577320 16432458 16248763 18332650 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.14 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.16 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.74 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
13.67 | 17415656 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
13.67 | 17488658 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.00 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.00 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.13 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.20 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.03 | 18259882 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.05 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.08 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
10.02 | 18481113 19348381 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
10.02 | 15640375 16889571 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.37 | 15555623 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.83 | 17378895 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.66 | 16049721 12819281 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.31 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.58 | 16525653 17393432 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.53 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.53 | 17638057 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.44 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.51 | 18437689 15749863 16729912 16868541 15897917 16888761 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
6.14 | 16882103 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
6.14 | 17410198 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
11.53 | 17922066 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
11.53 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.49 | 19058328 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.92 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.22 | 17203757 15625365 17710206 15675481 18313854 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.52 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.13 | 17846226 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.68 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.05 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.87 | 17203757 15625365 16767912 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.62 | 16503802 15862959 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.32 | 9562676 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.55 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.45 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.45 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.65 | 10091137 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.36 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
5.35 | 15577323 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.53 | 17638931 16364871 17334414 17678736 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.82 | 17120751 |